deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT02373865

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Randomized Double Blind Parallel Design Study Comparing Risk of Nocturnal Hypoglycemia and Critical Arrhythmia With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes Insufficiently Controlled With Metformin Monotherapy

Sponsor: GWT-TUD GmbH

Conditions Diabetes Mellitus Type 2
Interventions Glimepiride Glimepiride-Placebo Sitagliptin Sitagliptin-Placebo
Updated 10 times since 2017 Last updated: Oct 19, 2018 Started: Sep 30, 2015 Primary completion: Jan 31, 2017 Completion: Jan 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Premature termination due to insufficient patient recruitement..

Other terminated trials from GWT-TUD GmbH

More terminations from GWT-TUD GmbH

Other Diabetes Mellitus Type 2 trials with similar outcome

Browse all Diabetes Mellitus Type 2 trials

A PHASE4 clinical study on Diabetes Mellitus Type 2, this trial is terminated or withdrawn. The trial is conducted by GWT-TUD GmbH and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotTerminated~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE4

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE4

▶ Show 5 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE4

  2. Mar 2019 — Jan 2021 [monthly]

    Terminated PHASE4

  3. Jun 2018 — Mar 2019 [monthly]

    Terminated PHASE4

  4. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    Status: Recruiting → Terminated

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GWT-TUD GmbH
Data source: GWT-TUD GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations